Article Versions Notes

Garcia-Mesa Y, Xu HN, Vance P, Gruenewald AL, Garza R, Midkiff C, Alvarez-Hernandez X, Irwin DJ, Gill AJ, Kolson DL. Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. Antioxidants. 2021; 10(3):416. https://doi.org/10.3390/antiox10030416

Garcia-Mesa, Yoelvis, He N. Xu, Patricia Vance, Analise L. Gruenewald, Rolando Garza, Cecily Midkiff, Xavier Alvarez-Hernandez, David J. Irwin, Alexander J. Gill, and Dennis L. Kolson. 2021. "Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection" Antioxidants 10, no. 3: 416. https://doi.org/10.3390/antiox10030416

Garcia-Mesa, Y., Xu, H. N., Vance, P., Gruenewald, A. L., Garza, R., Midkiff, C., Alvarez-Hernandez, X., Irwin, D. J., Gill, A. J., & Kolson, D. L. (2021). Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. Antioxidants, 10(3), 416. https://doi.org/10.3390/antiox10030416